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ABSTRACT
Chest pain is one of the most common symptoms responsible for emergency department
and primary care office visits in the United States. Chest pain can be noncardiac and may be
attributed to multiple causes. Esophageal disorders including reflux, motility and functional
conditions, affect a large proportion of patients with NCCP and lead to significant morbidity.
The use of HRM has changed the diagnostic approach to esophageal motility disorders. It is the
most specific and sensitive test for diagnosing motor disorders and a promising procedure in
detecting dysmotility disorders in patients with NCCP. Despite the increased sensitivity of HRM,
the main indications for esophageal manometry exclude NCCP.
This study assessed the percentage of undiagnosed esophageal motility disorders in
patients with NCCP referred for high resolution manometry. Differences in HRM findings in
patients with NCCP versus patients meeting AGA recommendations for the clinical use of
esophageal manometry were also compared. A retrospective descriptive design was utilized.
Two hundred-nineteen patient charts were reviewed. One hundred sixty-eight (77%) patients
underwent HRM and met AGA recommendations for esophageal manometry; 51 (23%) patients
underwent the procedure after receiving a NCCP diagnosis.
Findings showed that 116 (69%) patients in the AGA group had abnormal findings while
52 (31%) did not. In the NCCP group 34 (67%) had abnormal findings compared to 17 (33%)
who did not. To compare normal and abnormal HRM findings in patients with NCCP versus
those meeting AGA criteria, Chi-Square analysis was performed between the groups. The results
were not statistically significant (p = 0.10).
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There were no significant differences in the results of HRM in both groups indicating the
findings on HRM are the same despite the indication for the procedure. The findings support the
use of HRM as a diagnostic tool in patients with chest pain after cardiac workup and endoscopic
evaluation. This indicates a possible need to update the AGA indications for esophageal
manometry and increase the awareness among healthcare providers regarding the use of HRM in
patients with chest pain. Implication for future research is also discussed.
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CHAPTER ONE: INTRODUCTION
Noncardiac chest pain (NCCP) is common in the general population (Fass & Achem,
2011). Almost 64% of patients presenting with chest pain are ultimately found to have NCCP as
a cause of their symptoms (Eslick, Coulshed, & Talley, 2005). The most recent data obtained
from the Centers for Disease Control and Prevention (CDC) suggests that over 11 million
patients with unspecified chest pain were seen in all ambulatory settings in 2009 (V. Beresovsky,
personal communication, October 26, 2011). This includes patients seen in hospital emergency
departments, hospital outpatient departments, physician offices, and clinics. These data are
presented in Table 1.
Noncardiac chest pain can also be a chronic condition and often has a benign course and
does not increase a patient’s mortality rate (Fass & Dickman, 2006; Richter, 1992). On the other
hand, NCCP results in high healthcare utilization and significant work absenteeism; it can
negatively impact patients’ quality of life (Fass & Achem, 2011). Patients with the condition can
have a history of multiple hospital admissions and frequently receive unsatisfactory diagnoses
despite multiple cardiac diagnostic workups and endoscopic evaluations (Leise et al., 2010).
NCCP patients are sometimes discharged from the hospital when signs and symptoms abate but
without a defined treatment plan or diagnosis (Eslick et al., 2005). After discharge, continuing
care can also be problematic as many of these patients continue to receive care by cardiologists
or primary care physicians without an appropriate diagnosis or determined cause for their chest
pain (Leise et al., 2010).
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Noncardiac chest pain may be attributed to multiple gastrointestinal, musculoskeletal,
pulmonary and psychological causes (Leise et al., 2010). Esophageal disorders including reflux,
motility, and functional conditions affect a large proportion of patients with NCCP and lead to
significant morbidity (Lazarescu, 2008).
Table 1: Number and Percent of Visits to Different Ambulatory Settings by Patients with
Diagnosis of Chest Pain in 2009
Ambulatory Setting

Visit (N)

Visit (SE)

Visit (%)

SE (%)

2,486,196
1,444,121
*
949,585

373,642
358,285
...
108,071

0.2
0.14
*
0.7

0.03
0.03
...
0.07

11,177,221
6,813,018
297,992
4,066,211

1,129,979
1,059,080
62,167
307,018

0.88
0.66
0.31
2.99

0.08
0.1
0.06
0.17

15,513,257
8,979,784
480,523
6,052,950

1,373,090
1,278,831
97,283
404,324

1.22
0.87
0.50
4.45

0.1
0.11
0.09
0.2

Other chest pain ‘786.59’
All ambulatory settings
Physician offices
Hospital Outpatient Departments
Hospital Emergency Departments
Chest pain, unspecified ‘786.50’
All ambulatory settings
Physician offices
Hospital Outpatient Departments
Hospital Emergency Departments
Chest pain ‘786.5’
All ambulatory settings
Physician offices
Hospital Outpatient Departments
Hospital Emergency Departments

Note. Adapted from “Number and Percent of Visits to Different Ambulatory Settings by Patients with Diagnosis of
Unspecified Chest Pain,” by National Center for Health Statistics /CDC, 2009.
(n) Number of visits
(SE) Standard error of number of visits
(%) Percent of annual visit volume
SE (%) Standard error of percent
*- Estimate does not meet NCHS standards of reliability.
… Inapplicable
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Problem Background
The National Hospital Ambulatory Medical Care Survey (1999–2008) reported chest pain
as the second most common reason for emergency department visits behind abdominal pain.
There were 5 million visits for chest pain between 1999 and 2000; and 5.5 million visits between
2007 and 2008 (Centers for Diseases Control and Prevention, 2010). The annual cost of
evaluation of NCCP is estimated to be between $315 million and $1.8 billion (Leise et al., 2010).
Symptoms of chest pain are a major source of concern for both patients and healthcare
providers because they can indicate an acute life-threatening event regardless of a history of
cardiac disease (Sheps, Creed, & Clouse, 2004). Patients’ history and characteristics do not
always distinguish between different causes of chest pain. And as a result, many patients seek
further medical attention when complaining of chest pain despite previous negative cardiac
workups and/or hospitalizations (Fass & Achem, 2011).
Esophageal disorders can also be the etiology of chest pain (Lemme, Moraes-Filho,
Domingues, Firman, & Pantoja, 2000). Gastroesophageal reflux disease (GERD) is the main
underlying mechanism of NCCP, accounting for up to 60 % of cases (Leise et al., 2010). NCCP
can also be caused by esophageal motor dysfunction; and the frequency may be underestimated.
Motor disorders are observed in almost 50% of patients with NCCP who ultimately undergo
conventional manometry evaluation (Gambitta et al., 1999).
The use of high resolution manometry (HRM) has changed the diagnostic approach to
esophageal motility disorders. It is the most specific and sensitive test for diagnosing motor
disorders and could be a promising diagnostic procedure in detecting dysmotility disorders in
patients with NCCP. The technique uses multiple high-fidelity sensors that capture manometric
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data as a spatial continuum without the substantial gaps between pressure sensors typically seen
with conventional manometry (Bansal & Kahrilas, 2010). Appendix A highlights the benefits of
high resolution manometry compared to conventional manometry.
Despite the increased sensitivity of HRM compared to conventional manometry, the main
indications for esophageal manometry remain unchanged. The most frequent indications for
esophageal manometry according to the American Gastroenterology Association (AGA) are
dysphagia, preoperative assessment of patients who are being considered for anti-reflux surgery,
and placement of intraluminal devices (e.g., pH probes) when position is dependent on the
relationship to functional landmarks, such as the lower esophageal sphincter (LES) (Pandolfino
& Kahrilas, 2005a). At present and since 2004, there is no specific recommendation from the
AGA for the use of esophageal manometry in patients with NCCP.
Research Questions
This study’s aim is to address two questions:
1. For patients with NCCP who are referred for HRM, what percentage is found to have
previously undiagnosed esophageal motility disorders?
2. Are there significant differences in HRM findings in patients with NCCP versus patients who
meet current AGA criteria for the use of esophageal manometry?
Purpose of Study
The purpose of this study is to (a) analyze manometric findings obtained with HRM in
patients with chest pain in whom cardiac causes were excluded and endoscopic evaluation was
unremarkable, (b) assess the importance of method and protocol in establishing a diagnosis of
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esophageal dysmotility, and (c) establish a more defined role for esophageal manometry in the
NCCP diagnostic protocol.
Definition of Terms
Non-Cardiac Chest Pain (NCCP)
Noncardiac Chest pain is defined as recurrent chest pain that is indistinguishable from
ischemic heart pain after a reasonable workup has excluded a cardiac cause (Fass & Achem,
2011).
High Resolution Esophageal Manometry
“High resolution manometry is a new technology used to measure intraluminal pressure
activity within the gastrointestinal tract using a series of closely spaced pressure sensors within
the esophagus. It uses a series of 36 1-cm-spaced pressure sensors that provides detailed pressure
information that reveals the segmental nature of esophageal peristalsis” (Parkman, McCallum, &
Rao, 2011, p. 22).
Esophageal Motor Dysfunction
Esophageal motor dysfunction is defined as the impairment of one or more of the
mechanisms necessary for normal esophageal function (Greenberger, Blumberg & Burakoff,
2009).
Implications for Practice
Noncardiac chest pain is a common challenge for healthcare providers with respect to
diagnostic strategy as well as therapeutic intervention for years (Minocha & Joseph, 1995). The
implications of this study on practice include: (a) proper diagnosis of patients with NCCP, (b)
increased patient satisfaction and quality of life through appropriate diagnosis and treatment, (c)
5

decrease patients’ anxiety which results from frequent diagnostic uncertainty, (d) increase
awareness among primary healthcare providers and cardiologists regarding the importance of
HRM in the evaluation of NCCP.
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CHAPTER TWO: LITERATURE REVIEW
Noncardiac Chest Pain
The definition of NCCP is complex. In a broad context, NCCP is chest pain that is not
related to angina or ischemic heart disease (Fox & Forgas, 2006). NCCP is further defined as
recurrent episodes of substernal chest pain or discomfort that remains unexplained after
nonesophageal causes such as cardiac, musculoskeletal, pleuritic, or pulmonary pathologies have
been excluded (Kachintorn, 2005). NCCP is not a recent pathophysiological phenomenon; it was
first recognized in 1860. It was called soldier’s heart as it described British soldiers who
presented with new onset chest pain during war (Minocha & Joseph, 1995).
Epidemiology
There are limited national and international epidemiological data on NCCP (Fass
&Achem, 2011). Internationally, one in four persons has an episode of chest pain annually
(Eslick et al., 2005). There is no difference in the prevalence of NCCP between males and
females (Kachintorn, 2005). However, females with NCCP tend to seek care more often than
men (Fass & Navarro-Rodriguez, 2008). Epidemiological studies have reported a decreased
prevalence of NCCP with increasing age. Females under the age of 25 and those between 45 and
55 years of age were found to have the highest prevalence rates (Fass & Dickerman, 2006; Eslick
& Fass, 2003).
Data also suggest patients with NCCP are often already actively under the care of a
physician, specialist, or other healthcare practitioner. Eslick and Tally (2004) found that 80% of
patients who presented to the emergency department with acute chest pain had seen a healthcare
provider within 12 months. The most common healthcare providers seen by patients in their
7

sample were general practitioners (85%), cardiologists (74%), gastroenterologists (30%),
pulmonologists (14%), alternative therapists (8%), and psychologists (10%).
In summary, NCCP is a common medical problem in the community that affects both
sexes equally. However, females are more likely to present to the emergency department for
evaluation of chest pain.
Causes
There are many common causes for NCCP that are not limited to the esophagus.
Pulmonary-, musculoskeletal-, infectious-, cardiovascular-, drug-, psychological-, and
gastroenterology-related disorders may present as atypical chest pain. Specific examples of these
conditions are listed in Table 2. The scope of this exposition will be limited to patients with
NCCP who presented to a gastroenterology office to rule out gastroenterology –related disorders
after cardiac workup was unremarkable.
Table 2: Common Non cardiac Chest Pain Causes
Musculoskeletal
 Costochondritis
 Fibromyalgia
 Precordial catch
syndrome
 Slipping rib syndrome
 Tietze’s syndrome

Gastrointestinal

Pulmonary
















Gastric
Biliary tree
Gallbladder
Pancreatic
Intra-abdominal
masses
 Esophageal causes:
o GERD
o Visceral
Hypersensitivity
o Esophageal
dysmotility

Pneumonia
Pulmonary embolism
Lung cancer
Sarcoidosis
Pneumothorax
Pneumomediastinum
Pleural effusions
Intrathoracic masses

Miscellaneous
 Aortic disorders
 Pericarditis and
myocarditis
 Pulmonary
hypertension
 Herpes zoster
 Drug-induced pain
 Sickle cell crises
 Psychological
disorders

Note. Adapted from “Noncardiac Chest Pain: Epidemiology, Natural Course and Pathogenesis,” by R. Fass and S.
Achem, 2011, Journal of Neurogastroenterology and Motility, 17, p. 112.

8

Functional Anatomy of the Esophagus
The esophagus and its sphincter act in coordination to perform the tasks of transporting
swallowed substances to the stomach and prevent the reflux of gastric contents while allowing
venting of gaseous gastric contents. Behind this coordination is a complex neuronal system
within the esophageal wall and the central nervous system (Bredenoord & Smout, 2008).
The esophagus is a 20-22 cm tube. It is composed of three functional regions: the upper
esophageal sphincter (UES), the esophageal body, and the LES. The UES is composed of striated
muscle. It is usually closed at rest and opens when a peristaltic pharyngeal contraction
approaches to allow bolus passage across the sphincter. The esophageal body is a muscular tube
that connects the UES and the LES. It consists of an inner circular muscle layer and outer
longitudinal muscle layer. There is a mesenteric plexus between the circular and longitudinal
muscle which regulates muscle actions. The enteric nervous system receives input from the
central nervous system. The LES consists of a circular smooth muscle thickening at the
esophageal gastric (GE) junction. The sphincter relaxes as the bolus enters the upper esophagus
and stays relaxed until the peristaltic contraction arrives at the GE junction (Bredenoord &
Smout, 2008).
Nature of Noncardiac Chest Pain
The close anatomical relationship between the esophagus and the heart contributes to the
similarity in symptoms and the difficulty in distinguishing the origin of chest pain. The
esophagus is located posterior to and is separated from the left atrium by the pericardium. Both
the heart and the esophagus share the same common path of pain fibers from the sympathetic
trunk (Heatley, Rose & Weston, 2005).
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Esophageal pain has many patterns. Patients usually describe it as burning, gripping,
stabbing, and pressing. In the anterior chest, the pain is usually in the throat or epigastrium and
sometimes radiates to the neck, back or upper arms. These symptoms may also apply to cardiac
pain (Bennett, 2001). Still, it is widely understood that the characteristic pain of GERD is
burning, epigastric, and related to recent food intake, lying down or bending (Bennett, 2001).
Pain as a result of esophageal spasms is retrosternal, deep and often labeled as burning,
squeezing or aching, usually radiating to the arms, jaw, and back (Heatley, Rose & Weston,
2004).
Many risk factors are associated with the development of coronary diseases, such as
smoking, obesity, and diabetes mellitus. Complicating the clinical picture, these risk factors also
increase the likelihood of esophageal disorders. Medical treatments designed for angina (e.g.,
nitroglycerin) often helps to relieve symptoms originating from the esophagus (Heatley, Rose &
Weston, 2004).
Pathophysiology
The potential for an esophageal etiology for recurring NCCP was originally hypothesized
by William Osler in 1892 (Castell, Talley, & Travis, 2010). The specific mechanisms for
esophageal-induced NCCP are poorly understood (Fang & Bjorkman, 2001). However, a few
possible mechanisms have been identified and include: irritant stimuli to the esophageal mucosa,
mechanical effects on the muscular wall, and visceral hypersensitivity (Castell et al., 2010).
Mucosal stimulation. Chest pain arises from esophageal mucosal irritation by acid
exposure. This causes discomfort in most patients. It usually resolves when acid perfusion ceases
(Bennett, 2001).
10

Mechanical changes. Alterations in esophageal motility can be a cause of chest pain.
This includes achalasia (absent distal peristalsis or abnormal relaxation of the LES), diffuse
esophageal spasm (DES) (simultaneous contractions or intermittent peristalsis), nutcracker
esophagus (increased contraction amplitude of over 180 mm Hg with normal peristalsis),
hypotensive LES, and ineffective esophageal motility (contractions of low amplitude or failed
and non-transmitted) (Bennett, 2001).
Visceral hypersensitivity. Chest pain caused by alterations in visceral receptor
sensitivity; the prevalence is higher in patients with anxiety, depression, somatization, and
neuroticism (Bennett, 2001).
Non Cardiac Chest Pain Cost
While the economic burden of NCCP has been proposed to be very high, studies
evaluating the cost and its impact on the healthcare system are scarce (Fass & Achem, 2011). In
one study, the healthcare costs for NCCP were estimated to be more than $315 million annually
(Richter, Barish, & Castell, 1986). And a more recent estimate put the cost at $1.8 billion
annually (Fang & Bjorkman, 2001). The high costs of NCCP are related to the need for frequent
clinic and emergency room visits, hospitalizations, and costly medications often prescribed to
NCCP patients. The cost excludes indirect expenses such as lost days of work, productivity and
the impact of symptoms on patients’ quality of life (Richter et al., 1986).
The cost of NCCP evaluations can be considerable. Thirty percent of coronary
angiograms performed in patients with chest pain are normal or have insignificant degrees of
obstruction. An estimated 1-1.5 million angiograms are performed annually. The long-term
mortality of NCCP patients is low with reported rates of < 1% at 10 years. Still, morbidity
11

remains high, accounting for the significant healthcare costs in treating these patients (Fang &
Bjorkman, 2001).
Non Cardiac Chest Pain Treatment Algorithm
An algorithm outlining an approach in patients with NCCP was published by Fang and
Bjorkman (2001) and is presented in Figure 1. While it has not been adopted by the AGA for
treating patients with NCCP, it includes the use of esophageal manometry as part of the NCCP
workup.

Figure 1: Unexplained cardiac chest pain algorithm. From “A Critical Approach to Noncardiac
Chest Pain: Pathophysiology, Diagnosis, and Treatment,” by J. Fang, and D. Bjorkman, 2001,
The American Journal of Gastroenterology, 96, p. 965. Copyright 2001 by Macmillan Publishers
Ltd. Reprinted with permission.
12

An Overview of High Resolution Manometry
High resolution manometry is the latest development in the recording of esophageal
pressure (Bredenoord & Smout, 2008). Conceptually, HRM refers to the use of multiple highfidelity sensors to capture manometric data as a spatial continuum without the substantial gaps
between sensors typical of conventional manometry (Bansal & Kahrilas, 2010). HRM provides
more data in comparison to conventional manometry (Park, 2010). It represents a refinement in
conventional methodology that provides greater detail by simplifying data interpretation (Hirano
& Pandolfino, 2007). It is designed to overcome the limitations of conventional manometric
systems (Park, 2010). Esophageal manometry has grown from a restricted technique in
specialized centers to a widespread clinical tool; and the number of studies assessing its efficacy
are increasing (Bredenoord & Smout, 2007).
History
The first manometric study was performed by Meltzer and Kronecker in 1883; and the
first pressure measurement of the esophagus was introduced in the late 1950s (DiMarino, Allen,
Lynn, & Zamani, 1998). Since then, there has been a stepwise improvement in the technique.
Earlier manometric evaluations were conducted using a pull through technique, where a catheter
with a few perfused side holes was used to identify pressure patterns in the esophagus. This
technique helped in recognizing a zone of high pressure at the GE junction. In addition,
peristalsis of the esophagus could be observed and the amplitude, duration, and velocity of the
propulsive contractions could be quantitated. This technique has difficulties mainly on LES
relaxation measurement at the GE junction as a result of a single point sensor. During
swallowing, the longitudinal muscles of the esophagus contract, resulting in an upward
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movement of the LES. This movement causes an issue in recording LES pressures since the
sphincter moves away from the point sensor, resulting in a recorded pressure decrease. In 1976,
this problem was solved with the addition of a sleeve sensor by Dent. The sleeve is a 6 cm
perfused membrane positioned along the distal end of the catheter which records the highest
pressure exerted along the membrane. Subsequently, the movement of an unrelaxed LES will not
influence pressure registration (Bredenoord & Smout, 2007).
A decade ago, a new advanced HRM, micro-manometry was introduced. The catheter
used in this HRM contains smaller lumina that are perfused at very low perfusion rates. This
improved catheter enables pressure monitoring with more sensors without overflowing the
esophagus with water. Micro-manometry allows the catheter to remain in one position while
studying peristalsis at 1-cm intervals in the entire esophagus (Bredenoord & Smout, 2007).
Indication for Esophageal Manometry
Esophageal manometry is considered the gold standard for esophageal motor function
assessment after mechanical obstruction and mucosal disease have been excluded by endoscopy
and/or barium swallow (Roman, Pandolfino, & Mion, 2009). HRM is clinically useful in the
evaluation of patients with nonstructural dysphagia, unexplained and/or NCCP, symptoms
suggestive of GERD, and prior to anti-reflux surgery (Katz, Menin, & Gideon, 2008). It is also
used to evaluate patients with generalized gastrointestinal tract disease such as scleroderma or
chronic idiopathic intestinal pseudo-obstruction (Lembo, Tally, & Travis, 2009)
According to the AGA, the utility of esophageal manometry in clinical practice resides in
three areas: (1) to accurately define esophageal motor function, (2) to define abnormal motor
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function, and (3) to delineate a treatment plan based on motor abnormalities (Pandolfino, &
Kahrilas, 2005b).
Esophageal manometry clinical practice guidelines were developed by the AGA to assist
gastroenterologists and other clinicians in the appropriate use of esophageal manometry in
patient care. The guidelines were approved by the Clinical Practice Committee on October 2,
2004, and by the AGA Governing Board on November 7, 2004 (Pandolfino, & Kahrilas, 2005a).
These guidelines are an update from previous recommendations published in 1994 and represent
the results of meticulous research into areas of controversy from the previous policy statement.
These recommendations take into account new technologies and techniques that may improve
and complement manometric diagnosis and are listed in Table 3 (Pandolfino, & Kahrilas, 2005a).
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Table 3: Summary of the Recommendations for the Clinical Use of Esophageal Manometry
Indication

Recommendations

Indicated

1. Manometry is indicated to establish the diagnosis of dysphagia in
patients in which a mechanical obstruction cannot be found and the
diagnosis of achalasia is suspected.
2. Manometric techniques are indicated for placement of intraluminal
devices (e.g., pH probes) when its positioning is dependent on the
relationship to functional landmarks, such as the LES.
3. Manometry is indicated for the preoperative assessment of patients who
are undergoing anti-reflux surgery.

Possibly indicated

1. Manometry is possibly indicated for the preoperative assessment of
peristaltic function in patients undergoing anti-reﬂux surgery.
2. Manometry is possibly indicated to assess symptoms of dysphagia in
patients who have undergone either anti-reﬂux surgery or treatment for
achalasia.

Not indicated

1. Manometry is not indicated for making or conﬁrming a suspected
diagnosis of GERD.
2. Manometry should not be routinely used as the initial test for chest pain
or other esophageal symptoms because of the low speciﬁcity of the
ﬁndings and the low likelihood of detecting a clinically signiﬁcant
motility disorder.

Note. From “American Gastroenterological Association medical position statement: Clinical use of esophageal
manometry,” by J. Pandolfino and P. Kahrilas, 2005, Gastroenterology, 128, p. 207. Copyright 2005 by Elsevier.
Adapted with permission.

The AGA recommendations for the clinical use of esophageal manometry do not include
assessment of patients with NCCP. This issue has been considered as the most controversial
application of esophageal manometry (Pandolfino, & Kahrilas, 2005b). Low specificity of the
esophageal manometry findings and the low likelihood of detecting a clinically significant
motility disorder have limited the clinical use of esophageal manometry in patients with NCCP
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(Pandolfino, & Kahrilas, 2005b). And while it remains absent from the guidelines, HRM has
been used successfully to detect motility diseases in patients with NCCP. For example,
Mehendiratta, DiMarino, and Cohen (2009) in their study showed a high clinical utility of
esophageal manometry in patients with dysphagia and/or NCCP. Figure 2 lists examples of
abnormal findings that can be evaluated by esophageal manometry.
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Classification of Esophageal Motor Abnormalities
Inadequate LES relaxation
• Achalasia: Failure of relaxation of LES with absent peristalsis in the body

Uncoordinated contraction
• Diffuse esophageal spasms (DES): Presence of simultaneous contractions >20% and <
100%

Hypercontraction
• Hypertensive lower esophageal sphincter (LES) LES basal pressure >45 mmHg and
normal esophageal peristalsis.
• Nutcracker esophagus (Hyperkinetic motility disorder): Presence of high amplitude
contractions (mean amplitude > 180 mmHg)in the distal esophagus but with normal
peristalic progression.

Segmental spasm (SEGS)
• Presence of simultaneous contractions limited to two adjacent recording channels with
peristalsis above and under them.

Hypocontraction
• Hypotensive LES: LES basal pressure < 10 mmHg with normal esophageal peristalsis
• Ineffective esophageal motility: Evidence of hypocontraction in the distal esophagus
with at least 30 % of wet swallows exhibiting any combination of the following
abnormalities: distal esophageal peristaltic wave amplitude < 30 mmHg, simultaneous
contractions with amplitude < 30 mmHg, failed peristalsis in which the peristaltic wave
does not traverse the entire length of the distal esophagus.
• Scleroderma esophagus: Reduced LES pressure < 10 mmHg and reduce or absent
peristalsis in the distal two-thirds of the esophahus body.

Non-specific esophageal motor disorder (NEMD)
• Any pattern of manometric abnormsalities not falling in the above categories
Figure 2. Esophageal Motor Abnormalities. From “Manometric Findings of Esophageal Motor
Disorders in 240 Brazilian Patients with Non-cardiac Chest Pain,” by E. M. Lemme, J. P.
Moraes-Filho, G. Domingues, C. G. Firman, and J. A. Pantoja , 2000, Diseases of the
Esophagus, 13, p. 118. Copyright 2000 by John Wiley and Sons. Adapted with permission. From
“Clinical Utility of Selective Esophageal Manometry in a Tertiary Care Settings,” by V.
Mehendiratta, A. DiMarino, and S. Cohen, 2009, Digestive Diseases and Sciences, 54, p. 1482.
Copyright 2009 by Springer Science and Business Media. Adapted with permission.
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The State of Science Regarding the Use of Esophageal Manometry in Patients
with Non Cardiac Chest Pain
Approximately 30% of patients undergoing cardiac workup have normal findings (Arora
& Katzka, 2011). One-third of patients with NCCP and non-GERD-related chest pain have
various esophageal motility abnormalities (Fass, 2008).
Esophageal manometry combined with acid perfusion has been found to be a safe and
reliable technique for the diagnosis of patients with NCCP since 1991. Pathologists discovered
abnormal findings in these NCCPs, including high-amplitude peristalsis and DES. Of the 275
patients, 90 patients had a positive response on combined esophageal manometry and acid
perfusion studies. The investigators recommended using esophageal manometry with acid
perfusion studies as a primary method for distinguishing esophageal pain from cardiac pain
(Crozier, Glick, Gibb, Ellis, & Veerman, 1991).
Similar findings were also found by Lemme et al. (2000). Esophageal manometry showed
abnormalities in 151 (63%) patients. The most frequent abnormal findings were non-specific
esophageal motor disorders (n = 60), and hypotensive LES (n = 54). Fifteen patients had
nutcracker esophagus, 4 DES, 11 segmental spasm, 6 achalasia, and 1 hypertensive LES. The
final conclusion of the study confirmed the usefulness of esophageal manometry in the
assessment of patients with NCCP. These authors also recommended patients with NCCP to be
referred for manometric evaluation.
Two most recent studies showed the role of esophageal manometry in patients with
NCCP. Dekel et al. (2003) assessed esophageal manometry in patients with NCCP and
dysphagia and discovered many had hypotensive LES in the NCCP group of the study,
ineffective peristalsis in the dysphagia study group, and achalasia in patients with combined
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symptoms of NCCP and dysphagia. Lacima, Grande, Pera, Francino, and Ros (2003) found that
ambulatory manometry had a small but perhaps important impact on the diagnosis of patient with
NCCP compared to standard esophageal testing.
In summary, not many studies have been dedicated to the evaluation of patients with
NCCP and esophageal motor dysfunction. However, while the studies mentioned above were all
supportive for the use of esophageal manometry in patients with NCCP, they assessed the role of
conventional manometry rather than HRM.
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CHAPTER THREE: METHODOLOGY
The focus of this study is to determine if HRM should play a more significant role in the
evaluation of patients with NCCP. The aim of this study is to (a) analyze manometric findings
obtained with HRM in patients with chest pain in whom cardiac causes were excluded and
endoscopic evaluation was unremarkable, (b) assess the importance of method and protocol in
establishing a diagnosis of esophageal dysmotility, and (c) establish a more defined role for
esophageal manometry in the NCCP diagnostic protocol.
Setting
The setting of this study was a gastroenterology office located in Maitland, Florida. It is a
private office including four board-certified gastroenterologists and one board-certified adult
nurse practitioner (ANP-BC). Esophageal manometry is one of multiple procedures performed at
this office and is usually done 5 days per week. The patients for esophageal manometry are
usually referred by gastroenterologists and surgeons. The most frequent indications for referrals
are dysphagia, intractable GERD, and preoperative assessment prior to anti-reflux surgery. These
patients are diverse in their race, gender, ethnicity, and socioeconomic status. They represent a
mix of health insurance coverage including private insurance, Orange County, Medicaid,
Medicare, self-pay, and others.
Design
This is a descriptive, cross sectional study that uses a two by two design.
Sample
The sample included 219 patients who underwent HRM from January 2009 to January
2012 and met the study’s inclusion criteria. The sample was grouped into: (a) NCCP group (n =
21

52) which included patients with chest pain and had negative cardiac workups; and (b) AGA
group (n = 168) which included patients who met the AGA criteria for esophageal manometry.
Both groups had negative endoscopic evaluation of any esophageal stricture. The inclusion
criteria included: (a) All patients must have had a negative endoscopic and/or barium swallow
evaluation for anatomical abnormalities, (b) All patients must have had an extensive cardiac
workup for chest pain which was non-diagnostic, and (c) patients must be 18 years of age or
above. Any patient who did not meet the above criteria was excluded. Data were collected
through retrospective chart review; therefore there was no contact with patients.
Procedure
Health records that met inclusion criteria were electronically accessed and reviewed. Data
were input into Excel spreadsheet and then transferred into the statistical analysis system (SAS)
version 9.2.
Study Variables
The demographic variables included age, gender, ethnicity/race and health insurance.
Table 4 specifies data collected for each variable.
Table 4: Demographic Data
Gender



Male
Female

Age








Ethnicity/Race



18-29
30-39
40-49
50-59
60-69
70-79
80-89
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White
African
American
Hispanic
Asian

Insurance



Yes
No

The dependent variable is the results/diagnosis found during the HRM procedure. The
independent variable is the use of HRM. Abnormal results included the diagnosis of any of the
following: Achalasia, nutcracker esophagus, hypotensive or hypertensive LES, DES, and
nonspecific findings.
Data Analysis
Descriptive statistics; including mean, standard deviation, range, frequency and
percentage, were calculated to describe the study sample (gender, age and ethnicity/race) and
summarize the results of the HRM procedures (achalasia, nutcracker esophagus, hypotensive
LES, hypertensive LES, DES, nonspecific findings, normal results in the three categories of
NCCP, mixed symptoms and indication of esophageal manometry group). Chi square was used
to address the research questions. SAS version 9.2 was used to analyze the data.
Ethical Considerations
This study did not require direct interaction with patients. Patients’ names were not
recorded from collected data. Instead, coded numbers were used to identify records within the
database. Therefore the potential for identification of patients’ names was eliminated. Consent
was not needed from patients. All medical records were kept on a computer housed in a locked
office. The study was approved by the Institutional Review Board of the University of Central
Florida.
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CHAPTER FOUR: FINDINGS
Introduction
The purpose of this study was to (a) analyze manometric findings obtained with HRM in
patients with chest pain in whom cardiac causes were excluded and endoscopic evaluation was
unremarkable, (b) assess the importance of method and protocol in establishing a diagnosis of
esophageal dysmotility, and (c) establish a more defined role for esophageal manometry in the
NCCP diagnostic protocol. The dependent variable is the results/diagnosis of the HRM. The
independent variable is the use of HRM. The demographic variables included age, gender,
ethnicity/race and health insurance status.
Frequency measures were used to answer the first research question: (1) For patients with
NCCP who are referred for HRM, what percentage is found to have previously undiagnosed
esophageal motility disorders? Chi-square with Fisher’s exact test was used to answer question
number two: (2) Are there significant differences in HRM findings in patients with NCCP versus
patients who meet current AGA criteria for the use of esophageal manometry? All data analyses
were performed with the use of SAS version 9.2.
Demographics
Over 3 years (January 2009 to January 2012), a total of two hundred nineteen patients
were studied by HRM at the Center for Advanced Gastroenterology office in Maitland, Florida.
One hundred sixty eight (77%) patients underwent HRM and fell under the AGA
recommendations for esophageal manometry. Fifty one (23%) patients with negative cardiac
evaluation underwent HRM to evaluate their chest pain. Before manometry, all patients
underwent endoscopy and obstructive lesions were excluded.
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Complete demographic data for the sample are shown in Table 5. The majority of
participants were female (74%), white (61%) and insured (99%) with a mean age of 57 ± 15.
Table 5: Demographic Data: Frequency and Percent
Variable

Frequency (n)

Percent (%)

Gender

Female
Male

163
56

74
26

Age

18-29
30-39
40-49
50-59
60-69
70-79
80-89

8
20
35
54
46
41
15

4
9
16
25
21
19
7

Ethnicity/Race

African American
Asian
Hispanic
Indian
White

46
6
33
1
133

21
3
15
0.5
61

Insurance

No
Yes

3
216

1
99

Note. The percentage was rounded to the nearest number
Percentages do not sum to a 100 due to rounding

Figures 3, 4 and 5 are graphical representations of the sample’s demographic data:
gender, age, and ethnicity/race.
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Gender
Male
26%

Female
74%

Figure 3. Gender

Age
54
46
41
35
20
15

8

18-29

30-39

40-49

50-59

Figure 4. Age

26

60-69

70-79

80-89

Ethnicity/Race
133

46
33
6
African
American

Asian

1
Hispanic

Indian

White

Figure 5. Ethnicity/Race
Research Questions
Question one: For patients with NCCP who are referred for HRM, what percentage is found to
have previously undiagnosed esophageal motility disorders?
The results of the HRM were divided into nine categories (achalasia, DES, hypertensive
LES, hypotensive LES, ineffective esophageal motility, nonspecific findings, nutcracker,
scleroderma, and normal). DES was the most prevalent abnormal finding in the NCCP group.
Esophageal manometry was abnormal in 67% of NCCP patients. Abnormalities included:
achalasia 6%, nutcracker esophagus 6%, DES 47%, hypotensive LES 20%, hypertensive LES
3%, scleroderma 3%, ineffective esophageal spasms 9%, and nonspecific findings 6%. Figures 6
and 7 provide graphical representation of HRM results in the NCCP group.
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NCCP Group
Normal

Abnormal

33%

67%

Figure 6: The Percentage of Normal and Abnormal HRM Findings in NCCP Group

Nonspecific
Findings
6%
Ineffective
esophageal
motility
9%

Nutcracker
esophagus
6%

NCCP
Scleroderma
3%

Achalasia
6%

DES
47%

Hypotensive LES
20%

Hypertensive LES
3%

Figure 7: The Percentage of Abnormal HRM Findings in NCCP Group
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Question two: Are there significant differences in HRM findings in patients with NCCP versus
patients who meet current AGA criteria for the use of esophageal manometry?
Results of HRM in the AGA group
Manometric abnormality was identified in 69% of patients in the AGA group.
Abnormalities included: achalasia 16%, nutcracker esophagus 13%, DES 27%, hypotensive LES
15%, hypertensive LES 4%, scleroderma 3%, ineffective esophageal spasms 6%, and
nonspecific findings 16%. Figures 8 and 9 provide graphical representations of HRM results in
the AGA group.

AGA Group
Abnormal

Normal

31%

69%

Figure 8: The Percentage of Normal and Abnormal HRM Findings in AGA Group
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AGA Group
Scleroderma
3%

Nonspecific
Findings
16%

Nutcracker
esophagus
13%

Achalasia
16%

DES
27%
Hypotensive LES
15%

Ineffective
esophageal
motility
6%

Hypertensive LES
4%

Figure 9: The Percentage of Abnormal HRM Findings in AGA Group

Table 6 compares the findings of HRM in both NCCP group and AGA group. It provides
data about the frequency and percent of each diagnosis / finding on HRM.
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Table 6: Results of High Esophageal Manometry
Diagnosis / Finding
Achalasia
DES
Hypertensive LES
Hypotensive LES
Ineffective esophageal motility
Nonspecific Findings
Nutcracker esophagus
Scleroderma
Normal

AGA Group
(n)
(%)
(n)
(%)
(n)
(%)
(n)
(%)
(n)
(%)
(n)
(%)
(n)
(%)
(n)
(%)
(n)
(%)

Total
Total Percentage

19
9
31
14
5
2
18
8
7
3
18
8
15
7
3
1
52
24
168
77

NCCP Group
2
1
16
7
1
0.5
7
3
3
1
2
1
2
1
1
0
17
8
51
23

Total
21
10
47
21
6
3
25
11
10
5
20
9
17
8
4
2
69
32
219
100

Note. The percentage was rounded to the nearest number
Percentages do not sum to a 100 due to rounding
(n) Frequency
(%) Percentage

Figure 10 provides a graphical comparison of the HRM results between NCCP group and
AGA group.
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Results of High Resolution Manometry
25
20
15
10
5
0

AGA Recommendations

NCCP

Figure 10: Results of High Resolution Manometry

The results of the HRM were grouped into two categories: (1) Abnormal findings
(achalasia, DES, hypertensive LES, hypotensive LES, ineffective esophageal motility,
nonspecific findings, nutcracker, and scleroderma), and (2) normal findings. In the AGA group,
116 patients (69%) had abnormal findings compared to 52 patients (31%) with normal study. In
the NCCP group, 34 patients (67%) had abnormal findings compared to 17 patients (33%) who
had normal study. Table 7 summarizes these findings.
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Table 7: Normal and Abnormal results of HRM in NCCP Group and AGA Group

Abnormal
Normal

Frequency
Percent
Frequency
Percent

Total
Total Percent

AGA

NCCP

Total

116
53
52
24
168
77

34
15
17
8
51
23

150
68
69
32
219
100

Note. The percentage was rounded to the nearest number

To compare normal and abnormal HRM findings between the NCCP group and AGA
group, Chi-Square analysis was performed. The results were not statistically significant (p =
0.10). In addition, the association between each diagnosis found on HRM (achalasia, DES,
hypertensive LES, hypotensive LES, ineffective esophageal motility, nonspecific findings,
nutcracker esophagus, scleroderma and normal results) between the two groups were
individually tested by Chi-Square. Furthermore, the Fisher’s Exact Test was used to assess
categories with less than 5. Table 8 illustrates the results of both Chi-Square and Fisher’s Exact
test results for each category. Diffuse esophageal spasms was the only category that was
statistically significant (p = 0.05).
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Table 8: Chi-Square and Fisher’s Exact Test Results
Fisher’s Exact Test
Achalasia
DES
Hypertensive LES
Hypotensive LES
Ineffective esophageal motility
Nonspecific Findings
Nutcracker esophagus
Scleroderma
Normal

Chi-Square

0.17
0.05
0.17
0.55
0.70
0.17
0.37
1.00
0.75
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CHAPTER FIVE: DISCUSSION
Detecting an esophageal motor disease allows healthcare providers to assure patients of
the benign nature of their condition and provide appropriate treatment. It can also help prevent
excessive hospital and physician visits as well as the costly and potentially risky testing which
often results.
The first aim of this study was to analyze manometric findings obtained with HRM in
patients with chest pain in whom cardiac causes were excluded and endoscopic evaluation was
unremarkable.
The findings of this study suggest HRM could play a role in the diagnostic workup in
patients with NCCP. Findings in 51 patients with NCCP were compared with findings in 168
patients who met AGA criteria for esophageal manometry. Structural causes were carefully
excluded by reviewing endoscopy results from each patient. Esophageal manometry was
abnormal in 67% of NCCP patients. Abnormalities included: achalasia 6%, nutcracker
esophagus 6%, DES 47%, hypotensive LES 20%, hypertensive LES 3%, scleroderma 3%,
ineffective esophageal spasms 9%, and nonspecific findings 6%.
Lemme et al. (2000) showed the majority of patients in their study had nonspecific
motility disorders (25%) and hypotensive LES (16%). Katz, Dalton, Richter, Wu, and Castell
(1987) found nutcracker as the most common abnormality (48%) followed by nonspecific motor
disorder (36%). This study showed the majority of patients to have DES (47%), followed by
hypotensive LES (20%). This finding is not consistent with the findings from previous literature.
A possible explanation is that this study used HRM, which is more sensitive and specific for
diagnosing motor disorders compared to these studies, which used conventional manometry. In
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addition, the high percentage of nonspecific findings on previous studies could be a misdiagnosis
of DES. This is because HRM is more likely to detect DES or other esophageal motor
dysfunction compared to conventional manometry.
The second aim of the study was to assess the importance of method and protocol in
establishing a diagnosis of esophageal dysmotility.
Esophageal manometry continues to be of high clinical utility in management of patients
with dysphagia after exclusion of mechanical causes. As a result, the main indication for
esophageal manometry according to the AGA is dysphagia. However, this study found
esophageal manometry to be useful and suggested that perhaps it should play a more prominent
role in the evaluation of patients with NCCP. Patients in both groups (AGA and NCCP) had
manometric findings that were similar independent of the indication of the esophageal
manometry.
The third aim of the study was to establish a more defined role for esophageal
manometry in the NCCP diagnostic protocol.
Evaluation of chest pain is the most controversial application of esophageal manometry
(Mehendiratta et al., 2008). The literature review that was published by the AGA mentioned that
“most patients with chest pain are found to have nonspecific disorders such as those associated
with exaggerated contractions in the esophageal body (nutcracker esophagus, hypertensive LES)
or those associated with hypotensive LES” (Pandolfino & Kahrilas, 2005 b, p. 219). Therefore,
AGA guidelines do not recommend the use of esophageal manometry for initial evaluation of
chest pain (even after cardiac and endoscopic workup) as a result of “low specificity of the
findings and the low likelihood of detecting a clinically significant motility disorder” (Pandolfino
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& Kahrilas, 2005 b, p. 219). Their argument is based on prior studies that reported low
incidence of motility disorders (e.g. DES) in patients with NCCP.
Dalton, Castell, Hewson, Wu, & Richter (1991) found that DES is an uncommon motility
disorder that is found in less than 5% of patients with chest pain. Consequently, the
recommendation was to ignore this diagnosis and to focus on other causes for unexplained chest
pain. American Gastroenterological Association recommendations for esophageal manometry
were based on studies conducted over 20 years ago that employed “conventional” and “pull
through” procedures which are less sensitive than HRM. However, this study provided a crosssection of patients with NCCP. Diffuse esophageal spasms was the most common manometric
abnormality seen in 16 (47 %) patients. This could be explained by the use of HRM which is
more specific and sensitive for diagnosing motor disorders of the esophagus as compared to
conventional manometry. Based on the results of this study, the AGA might need to reassess
their recommendation for the use of high resolution manometry.
Findings of this study suggest esophageal manometry could play a more pivotal role in
the evaluation of NCCP. Esophageal manometry was made a part of the NCCP workup
algorithm and its use would be optimized if healthcare providers were educated on the data
supporting it as a diagnostic tool.
Chest pain is an ongoing problem and will continue to be an elusive issue if proper
diagnosis is not made for NCCP patients. Many have been seeking medical help as a result of
chest pain with repeated cardiac workup and recurrent admission to hospitals. The underuse of
HRM has clearly led some patients to remain undiagnosed and thus, suffer needlessly. In turn,
this places a significant burden on an already financially strained healthcare system. This study
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demonstrates that a brief 30 minute, minimally invasive, and affordable ($200-300) study could
provide a diagnosis for many patients who continue to suffer the stress of physical pain and
diagnosis uncertainty. One cannot quantify the possibly improved quality of live and peace of
mind associated with such a diagnosis and the assurance of a benign course.
Study Strengths
This is potentially the first study to use HRM to look at the percentage of normal and
abnormal findings in patients with NCCP. It is also the first to evaluate the differences in HRM
findings in patients with NCCP versus those with an AGA indication for the clinical use of
esophageal manometry. In addition, all previous studies reviewed assessed conventional
manometry. Moreover, most of the studies that were included in the literature review were
conducted outside the United States while this one was domestic.
Limitations
The limitation of the study relates to the issues that result with any retrospective chart
review; data collected are limited to the information on medical charts and electronic medical
records. Another limitation of the study is the sample size. The sample is limited to only patients
from Central Florida and from one clinical practice. In addition, most of the NCCP patients were
females. However, this finding seems to be compatible with the results from previous studies.
These limitations could threaten the generalizability of the findings from the study.
Future Research
The present study provides a basis for further research studies. This study could be
replicated in the future using data from multiple centers across the country, which would allow a
bigger sample size and more generalizability. In addition, a new study to follow patients after
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diagnosis and treatment based on HRM is recommended to evaluate the impact of this procedure
in patients’ perception of chest pain, recurrence of emergency department visits, hospital
admissions, and healthcare providers’ office visits would be essential.
Conclusion
The proportion of patients suffering from chest pain in the United States is high. Nearly,
all patients with NCCP experience a decreased functionality and quality of life regardless of the
cause of the pain, partly from fear of myocardial infarction. There are many causes of chest pain
and it is difficult to identify the cause based simply on patients’ descriptions and described
characteristics of pain (Lenfant, 2010).
In summary, this study is the first to evaluate the use of HRM in patients with NCCP.
Based on the results of the present data, the usefulness of HRM in assessing patients with NCCP
is strengthened. As a result, patients with NCCP might benefit from HRM studies. In addition,
the AGA might need to reassess their criteria for the use of esophageal manometry as a tool in
the evaluation of NCCP.
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APPENDIX A: BENEFITS OF HIGH RESOLUTION MANOMETRY
COMPARED TO CONVENTIONAL MANOMETRY
Benefits of high resolution manometry compared to conventional manometry
Conventional manometry


High-resolution manometry

Need to move catheter for LES in most



Catheter stays in one position



Solid state and direct interface with

systems


Water-perfused systems are
multicomponent and cumbersome

stand-alone system



Low fidelity



High fidelity



Waveforms only



Color contour



LES measurements complex: some use



No need for pull-through technique,

sleeves, others need station pull-

and if desired can create an electronic

through technique

sleeve for LES determination



Hard to find hiatal hernias



Hiatal hernias are immediately visible



Water-perfused catheters are stiff and



Soft and comfortable



Procedure is quicker since no position

more uncomfortable


Multiple maneuvers mean a longer test
duration



changes are needed


Large gaps between pressure channels
(most are 5 cm apart); may miss

Array of 36 channels straddle the entire
esophagus; sees the entire organ

findings
Note. From Color Atlas of High Resolution Manometry (p. 12), by J. Conklin, M. Pimentel and E. Soffer, 2009, New
York: Springer . Copyright 2009 by Springer. Reprinted with permission.
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